JP Morgan Chase’s CytRx Corp CYTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-15,447
Closed -$41K 5505
2017
Q1
$41K Sell
15,447
-6,613
-30% -$16.7K ﹤0.01% 4583
2016
Q4
$49K Buy
+22,060
New +$64.8K ﹤0.01% 4559
2014
Q4
Sell
-221,914
Closed -$3.38M 4563
2014
Q3
$3.38M Sell
221,914
-54,872
-20% -$1.08M ﹤0.01% 2607
2014
Q2
$6.94M Sell
276,786
-39,536
-12% -$901K ﹤0.01% 1926
2014
Q1
$6.62M Buy
316,322
+11,360
+4% +$403K ﹤0.01% 1933
2013
Q4
$11.5M Buy
+304,962
New +$5.55M ﹤0.01% 1691

Other funds holding CYTR

JP Morgan Chase's CYTR Position: Q2 2017 in Review

JP Morgan Chase sold out of CytRx Corp (CYTR) in Q2 2017, closing a stake of 15,447 shares — an estimated $41K sold.

JP Morgan Chase first reported a position in CYTR in Q4 2013 and held it in 6 quarters. The position peaked at $11.5M in Q4 2013. 54 funds tracked by Wall St. Rank hold CYTR as of Q2 2017.

  • JP Morgan Chase reported no remaining CytRx Corp position as of Q2 2017 after selling out during the quarter.
  • JP Morgan Chase sold 15,447 CytRx Corp shares in Q2 2017, an estimated $41K.
  • JP Morgan Chase first reported a position in CytRx Corp in Q4 2013 and held it in 6 quarters.
  • JP Morgan Chase's CytRx Corp position peaked at $11.5M in Q4 2013.
  • 54 funds tracked by Wall St. Rank held CytRx Corp as of Q2 2017.

Based on JP Morgan Chase's 13F filing for Q2 2017, filed 9 Aug 2017.